INS and metabolic disease: Also, Zlatkina, in her 2016 paper, concludes that increased blood serum VASP levels may precede changes in insulin levels in children, and that monitoring of VASP levels may allow a group at high risk of developing metabolic disease and hypertension in the future to be more quickly identified (51).